Tekla Capital Management as of March 31, 2015
Portfolio Holdings for Tekla Capital Management
Tekla Capital Management holds 101 positions in its portfolio as reported in the March 2015 quarterly 13F filing
Company (Ticker) |
Portfolio Weight |
Valued At |
Change in Shares |
Share Count |
Share Price |
|---|---|---|---|---|---|
| Gilead Sciences (GILD) | 10.5 | $266M | 2.7M | 98.13 | |
| Celgene Corporation | 9.1 | $230M | 2.0M | 115.28 | |
| Biogen Idec (BIIB) | 5.9 | $149M | 352k | 422.21 | |
| Actavis | 4.3 | $108M | 362k | 297.62 | |
| Alexion Pharmaceuticals | 4.0 | $100M | 580k | 173.30 | |
| Incyte Corporation (INCY) | 3.6 | $91M | 993k | 91.66 | |
| Regeneron Pharmaceuticals (REGN) | 3.4 | $85M | 187k | 451.48 | |
| Abbvie (ABBV) | 3.0 | $77M | 1.3M | 58.54 | |
| BioMarin Pharmaceutical (BMRN) | 2.6 | $67M | 535k | 124.62 | |
| Teva Pharmaceutical Industries (TEVA) | 2.5 | $62M | 998k | 62.30 | |
| Mylan Nv | 2.4 | $60M | 1.0M | 59.35 | |
| Pfizer (PFE) | 2.3 | $57M | 1.6M | 34.79 | |
| Amgen (AMGN) | 2.2 | $56M | 352k | 159.85 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 2.2 | $55M | 464k | 117.97 | |
| Johnson & Johnson (JNJ) | 1.7 | $44M | 435k | 100.60 | |
| Akorn | 1.6 | $40M | 850k | 47.51 | |
| Alkermes (ALKS) | 1.4 | $36M | 589k | 60.97 | |
| Aetna | 1.4 | $35M | 332k | 106.53 | |
| Bristol Myers Squibb (BMY) | 1.4 | $35M | 535k | 64.50 | |
| Perrigo Company (PRGO) | 1.3 | $33M | 198k | 165.55 | |
| Illumina (ILMN) | 1.2 | $30M | 163k | 185.65 | |
| Synageva Biopharma | 1.0 | $26M | 270k | 97.54 | |
| Catamaran | 1.0 | $26M | 434k | 59.54 | |
| Molina Healthcare (MOH) | 0.9 | $23M | 348k | 67.29 | |
| Acorda Therapeutics | 0.9 | $23M | 681k | 33.28 | |
| Endo International | 0.9 | $23M | 252k | 89.70 | |
| Baxter International (BAX) | 0.9 | $22M | 320k | 68.50 | |
| Ventas (VTR) | 0.8 | $21M | 293k | 73.02 | |
| Allscripts Healthcare Solutions (MDRX) | 0.8 | $21M | 1.8M | 11.96 | |
| Jazz Pharmaceuticals (JAZZ) | 0.8 | $21M | 121k | 172.79 | |
| Receptos | 0.8 | $21M | 125k | 164.89 | |
| Neurocrine Biosciences (NBIX) | 0.8 | $20M | 501k | 39.71 | |
| iShares NASDAQ Biotechnology Index (IBB) | 0.8 | $20M | 58k | 343.44 | |
| Alnylam Pharmaceuticals (ALNY) | 0.8 | $19M | 185k | 104.42 | |
| Thermo Fisher Scientific (TMO) | 0.8 | $19M | 142k | 134.34 | |
| Physicians Realty Trust | 0.7 | $19M | 1.1M | 17.61 | |
| Medical Properties Trust (MPW) | 0.7 | $17M | 1.2M | 14.74 | |
| Omega Healthcare Investors (OHI) | 0.7 | $17M | 413k | 40.57 | |
| Impax Laboratories | 0.6 | $16M | 345k | 46.87 | |
| Corsicanto Ltd conv bnd | 0.6 | $16M | 15M | 1.07 | |
| McKesson Corporation (MCK) | 0.6 | $15M | 68k | 226.19 | |
| Sabra Health Care REIT (SBRA) | 0.6 | $15M | 456k | 33.15 | |
| Alere | 0.6 | $15M | 298k | 48.90 | |
| Karyopharm Therapeutics (KPTI) | 0.6 | $15M | 477k | 30.61 | |
| Community Health Systems (CYH) | 0.5 | $14M | 260k | 52.28 | |
| Health Care Reit Pfd I 6.5% | 0.5 | $13M | 200k | 67.16 | |
| Verastem | 0.5 | $13M | 1.2M | 10.17 | |
| Heron Therapeutics (HRTX) | 0.5 | $13M | 874k | 14.55 | |
| Ironwood Pharmaceuticals (IRWD) | 0.5 | $12M | 768k | 16.00 | |
| Zimmer Holdings (ZBH) | 0.5 | $12M | 102k | 117.52 | |
| Stryker Corporation (SYK) | 0.5 | $11M | 124k | 92.25 | |
| Hca Holdings (HCA) | 0.4 | $11M | 148k | 75.23 | |
| LTC Properties (LTC) | 0.4 | $11M | 237k | 46.00 | |
| Achillion Pharmaceuticals | 0.4 | $11M | 1.1M | 9.86 | |
| Merck & Co (MRK) | 0.4 | $11M | 185k | 57.48 | |
| Sangamo Biosciences (SGMO) | 0.4 | $11M | 679k | 15.68 | |
| St. Jude Medical | 0.4 | $11M | 162k | 65.40 | |
| Senior Housing Properties Trust | 0.4 | $11M | 480k | 22.19 | |
| CIGNA Corporation | 0.4 | $9.6M | 74k | 129.44 | |
| Sagent Pharmaceuticals | 0.4 | $9.5M | 410k | 23.25 | |
| Endologix | 0.4 | $9.4M | 551k | 17.07 | |
| Agios Pharmaceuticals (AGIO) | 0.4 | $9.5M | 100k | 94.30 | |
| Therapeuticsmd | 0.4 | $9.0M | 1.5M | 6.05 | |
| IDEXX Laboratories (IDXX) | 0.3 | $8.7M | 56k | 154.48 | |
| Centene Corporation (CNC) | 0.3 | $8.5M | 120k | 70.69 | |
| WellCare Health Plans | 0.3 | $8.1M | 89k | 91.46 | |
| Accuray Incorporated (ARAY) | 0.3 | $6.8M | 732k | 9.30 | |
| Merrimack Pharmaceuticals In | 0.3 | $6.7M | 568k | 11.88 | |
| Bluebird Bio (BLUE) | 0.3 | $6.6M | 55k | 120.77 | |
| Infinity Pharmaceuticals (INFIQ) | 0.2 | $6.1M | 439k | 13.98 | |
| athenahealth | 0.2 | $5.5M | 46k | 119.39 | |
| Myriad Genetics (MYGN) | 0.2 | $5.3M | 150k | 35.40 | |
| Momenta Pharmaceuticals | 0.2 | $5.4M | 354k | 15.20 | |
| Aegerion Pharmaceuticals | 0.2 | $5.4M | 206k | 26.17 | |
| Kite Pharma | 0.2 | $5.4M | 93k | 57.68 | |
| Actavis Plc Conv Pfd Ser A pfd conv ser a | 0.2 | $5.1M | 5.0k | 1012.00 | |
| Supernus Pharmaceuticals note 7.500 5/0 | 0.2 | $4.8M | 2.0M | 2.41 | |
| Trovagene | 0.2 | $4.4M | 650k | 6.81 | |
| Sarepta Therapeutics (SRPT) | 0.2 | $4.6M | 345k | 13.28 | |
| Flex Pharma | 0.2 | $4.6M | 233k | 19.60 | |
| Spectrum Pharmaceuticals Inc conv | 0.2 | $4.6M | 5.0M | 0.91 | |
| Wright Medical | 0.2 | $4.0M | 156k | 25.80 | |
| Zogenix | 0.1 | $3.9M | 2.9M | 1.37 | |
| Intellipharmaceuticsintl Inc C | 0.1 | $3.9M | 1.4M | 2.79 | |
| Epizyme | 0.1 | $3.8M | 200k | 18.78 | |
| Intra Cellular Therapies (ITCI) | 0.1 | $3.6M | 150k | 23.88 | |
| Accelr8 Technology | 0.1 | $3.3M | 145k | 22.50 | |
| Tenet Healthcare Corporation (THC) | 0.1 | $2.9M | 60k | 49.51 | |
| Merrimack Pharmaceuticals In note 4.500% 7/1 | 0.1 | $2.9M | 1.5M | 1.97 | |
| Kythera Biopharmaceuticals I | 0.1 | $2.8M | 56k | 50.15 | |
| BioDelivery Sciences International | 0.1 | $2.6M | 250k | 10.50 | |
| Immunomedics | 0.1 | $1.9M | 500k | 3.83 | |
| Sorrento Therapeutics (SRNE) | 0.1 | $1.6M | 143k | 11.56 | |
| Eleven Biotherapeutics | 0.1 | $1.7M | 196k | 8.92 | |
| Bellicum Pharma | 0.1 | $1.4M | 60k | 23.17 | |
| Cellectis S A (CLLS) | 0.1 | $1.4M | 40k | 34.60 | |
| Sage Therapeutics (SAGE) | 0.0 | $753k | 15k | 50.20 | |
| Macrogenics (MGNX) | 0.0 | $400k | 13k | 31.39 | |
| Zafgen | 0.0 | $527k | 13k | 39.60 | |
| OncoGenex Pharmaceuticals | 0.0 | $243k | 113k | 2.15 | |
| Xencor (XNCR) | 0.0 | $306k | 20k | 15.30 |
